Source link : https://newshealth.biz/health-news/jak-inhibitor-benefits-in-type-1-diabetes-lost-after-discontinuation/
(MedPage Today) — The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After treatment was stopped, C-peptide… Source link : https://www.medpagetoday.com/meetingcoverage/easd/117538 Author : Publish date : 2025-09-18 22:01:00 Copyright for syndicated content belongs to the […]
The post JAK Inhibitor Benefits in Type 1 Diabetes Lost After Discontinuation first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-18 22:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8